49 related articles for article (PubMed ID: 24102075)
1. Fusobacterium nucleatum induces cytokine production through Toll-like-receptor-independent mechanism.
Quah SY; Bergenholtz G; Tan KS
Int Endod J; 2014 Jun; 47(6):550-9. PubMed ID: 24102075
[TBL] [Abstract][Full Text] [Related]
2. Tannerella forsythia scavenges Fusobacterium nucleatum secreted NOD2 stimulatory molecules to dampen oral epithelial cell inflammatory response.
Settem RP; Ruscitto A; Chinthamani S; Honma K; Sharma A
Mol Oral Microbiol; 2024 Apr; 39(2):40-46. PubMed ID: 37459655
[TBL] [Abstract][Full Text] [Related]
3. Fusobacterium nucleatum transports noninvasive Streptococcus cristatus into human epithelial cells.
Edwards AM; Grossman TJ; Rudney JD
Infect Immun; 2006 Jan; 74(1):654-62. PubMed ID: 16369022
[TBL] [Abstract][Full Text] [Related]
4. Induction of apoptotic cell death in peripheral blood mononuclear and polymorphonuclear cells by an oral bacterium, Fusobacterium nucleatum.
Jewett A; Hume WR; Le H; Huynh TN; Han YW; Cheng G; Shi W
Infect Immun; 2000 Apr; 68(4):1893-8. PubMed ID: 10722579
[TBL] [Abstract][Full Text] [Related]
5. Unveiling Therapeutic Potential: Targeting
Boreak N; Alrajab EA; Nahari RA; Najmi LE; Masmali MA; Ghawi AA; Al Moaleem MM; Alhazmi MY; Maqbul AA
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673822
[TBL] [Abstract][Full Text] [Related]
6. Electro-antibacterial therapy (EAT) to enhance intracellular bacteria clearance in pancreatic cancer cells.
Duncan JL; Ahmad RN; Danesi H; Slade DJ; Davalos RV; Verbridge SS
Bioelectrochemistry; 2024 Jun; 157():108669. PubMed ID: 38377890
[TBL] [Abstract][Full Text] [Related]
7. Diverse Toll-like receptors mediate cytokine production by Fusobacterium nucleatum and Aggregatibacter actinomycetemcomitans in macrophages.
Park SR; Kim DJ; Han SH; Kang MJ; Lee JY; Jeong YJ; Lee SJ; Kim TH; Ahn SG; Yoon JH; Park JH
Infect Immun; 2014 May; 82(5):1914-20. PubMed ID: 24566622
[TBL] [Abstract][Full Text] [Related]
8. Fusobacterium nucleatum, inflammation, and immunity: the fire within human gut.
Bashir A; Miskeen AY; Hazari YM; Asrafuzzaman S; Fazili KM
Tumour Biol; 2016 Mar; 37(3):2805-10. PubMed ID: 26718210
[TBL] [Abstract][Full Text] [Related]
9. Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy.
Yu T; Guo F; Yu Y; Sun T; Ma D; Han J; Qian Y; Kryczek I; Sun D; Nagarsheth N; Chen Y; Chen H; Hong J; Zou W; Fang JY
Cell; 2017 Jul; 170(3):548-563.e16. PubMed ID: 28753429
[TBL] [Abstract][Full Text] [Related]
10. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack.
Gur C; Ibrahim Y; Isaacson B; Yamin R; Abed J; Gamliel M; Enk J; Bar-On Y; Stanietsky-Kaynan N; Coppenhagen-Glazer S; Shussman N; Almogy G; Cuapio A; Hofer E; Mevorach D; Tabib A; Ortenberg R; Markel G; Miklić K; Jonjic S; Brennan CA; Garrett WS; Bachrach G; Mandelboim O
Immunity; 2015 Feb; 42(2):344-355. PubMed ID: 25680274
[TBL] [Abstract][Full Text] [Related]
11. The Role of
Pignatelli P; Nuccio F; Piattelli A; Curia MC
Microorganisms; 2023 Sep; 11(9):. PubMed ID: 37764202
[TBL] [Abstract][Full Text] [Related]
12. The Role of Oral Fusobacterium nucleatum in Female Breast Cancer: A Systematic Review and Meta-Analysis.
Gaba FI; González RC; Martïnez RG
Int J Dent; 2022; 2022():1876275. PubMed ID: 36466367
[TBL] [Abstract][Full Text] [Related]
13. Fusobacterium nucleatum: a new player in regulation of cancer development and therapeutic response.
Zhao T; Wang X; Fu L; Yang K
Cancer Drug Resist; 2022; 5(2):436-450. PubMed ID: 35800370
[TBL] [Abstract][Full Text] [Related]
14. Microbiome and colorectal carcinogenesis: Linked mechanisms and racial differences.
Tortora SC; Bodiwala VM; Quinn A; Martello LA; Vignesh S
World J Gastrointest Oncol; 2022 Feb; 14(2):375-395. PubMed ID: 35317317
[TBL] [Abstract][Full Text] [Related]
15. Oral streptococci subvert the host innate immune response through hydrogen peroxide.
Tang YL; Sim TS; Tan KS
Sci Rep; 2022 Jan; 12(1):656. PubMed ID: 35027607
[TBL] [Abstract][Full Text] [Related]
16. Fusobacterium nucleatum and oral cancer: a critical review.
McIlvanna E; Linden GJ; Craig SG; Lundy FT; James JA
BMC Cancer; 2021 Nov; 21(1):1212. PubMed ID: 34774023
[TBL] [Abstract][Full Text] [Related]
17. Immune System, Microbiota, and Microbial Metabolites: The Unresolved Triad in Colorectal Cancer Microenvironment.
Hanus M; Parada-Venegas D; Landskron G; Wielandt AM; Hurtado C; Alvarez K; Hermoso MA; López-Köstner F; De la Fuente M
Front Immunol; 2021; 12():612826. PubMed ID: 33841394
[TBL] [Abstract][Full Text] [Related]
18. Serrated neoplasia in the colorectum: gut microbiota and molecular pathways.
Kang X; Zhang R; Kwong TN; Lui RN; Wu WK; Sung JJ; Yu J; Wong SH
Gut Microbes; 2021; 13(1):1-12. PubMed ID: 33382354
[TBL] [Abstract][Full Text] [Related]
19. Potential Use of Biotherapeutic Bacteria to Target Colorectal Cancer-Associated Taxa.
Lawrence GW; Begley M; Cotter PD; Guinane CM
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019270
[TBL] [Abstract][Full Text] [Related]
20.
Yang Z; Ji G
Oncol Lett; 2019 Aug; 18(2):975-982. PubMed ID: 31423156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
